| 臺大學術典藏 |
2022-09-16T03:41:52Z |
Investigation of the mechanism of transdermal penetration enhancer: A comparison of multiphoton microscopy and electron microscopy
|
SUNG-JAN LIN; Lee J.-N.; Lin C.-Y.; Chan C.-C.; Lin M.-G.; Wang C.-C.; Tan H.-Y.; Tsai T.-H.; Jee S.-H.; Dong C.-Y. |
| 臺大學術典藏 |
2022-09-16T03:41:47Z |
Differentiation of normal and cancerous lung tissues by multiphoton imaging
|
Wang C.-C.; Li F.-C.; Wu R.-J.; Hovhannisyan V.A.; Lin W.-C.; SUNG-JAN LIN; So P.T.C.; Dong C.-Y. |
| 臺大學術典藏 |
2022-09-16T03:41:44Z |
Label-free discrimination of normal and pulmonary cancer tissues using multiphoton fluorescence ratiometric microscopy
|
Wang C.-C.; Wu R.-J.; SUNG-JAN LIN; Chen Y.-F.; Dong C.-Y. |
| 臺大學術典藏 |
2022-09-16T03:41:44Z |
Differentiation of normal and cancerous lung tissues by multiphoton imaging
|
Wang C.-C.; Li F.-C.; Wu Jr. R.; Hovhannisyan V.A.; Lin W.-C.; SUNG-JAN LIN; So P.T.C.; Dong C.-Y. |
| 臺大學術典藏 |
2022-09-16T03:41:43Z |
Early development of cutaneous cancer revealed by intravital nonlinear optical microscopy
|
Wang C.-C.; Li F.-C.; Lin W.-C.; Chen Y.-F.; Chen S.-J.; SUNG-JAN LIN; Dong C.-Y. |
| 臺大學術典藏 |
2022-09-16T03:41:41Z |
erratum: Label-free discrimination of normal and pulmonary cancer tissues using multiphoton fluorescence ratiometric microscopy (Applied Physics letter (2010) 97 (043706))
|
Wang C.-C.; Wu R.-J.; SUNG-JAN LIN; Chen Y.-F.; Dong C.-Y. |
| 臺大學術典藏 |
2022-09-16T03:41:39Z |
Visualizing radiofrequency-skin interaction using multiphoton microscopy in vivo
|
Tsai T.-H.; SUNG-JAN LIN; Lee W.-R.; Wang C.-C.; Hsu C.-T.; Chu T.; Dong C.-Y. |
| 臺大學術典藏 |
2022-09-15T02:44:08Z |
Amantadine treatment and delayed onset of levodopa-induced dyskinesia in patients with early Parkinson's disease
|
Wang C.-C.; Wu T.-L.; Lin F.-J.; Tai C.-H.; CHIN-HSIEN LIN; Wu R.-M. |
| 臺大學術典藏 |
2022-09-15T01:09:04Z |
Nuclear factor-κB overexpression is correlated with poor outcomes after multimodality bladder-preserving therapy in patients with muscle-invasive bladder cancer
|
Chiang Y.; Wang C.-C.; Tsai Y.-C.; Huang C.-Y.; Pu Y.-S.; Chia-Chi Lin; Cheng J.C.-H. |
| 臺大學術典藏 |
2022-09-15T01:08:49Z |
Phase I Dose-Escalation Study of SCB01A, a Microtubule Inhibitor with Vascular Disrupting Activity, in Patients with Advanced Solid Tumors
|
Shiah H.-S.; Chiang N.-J.; Chia-Chi Lin; Yen C.-J.; Tsai H.-J.; Wu S.-Y.; Su W.-C.; Chang K.-Y.; Wang C.-C.; Chang J.-Y.; Chen L.-T. |
| 臺大學術典藏 |
2022-09-15T01:08:46Z |
Phase 1b Open-Label Trial of Afatinib Plus Xentuzumab (BI 836845) in Patients With EGFR Mutation-Positive NSCLC After Progression on EGFR Tyrosine Kinase Inhibitors
|
Park K.; Tan D.S.W.; Su W.-C.; Cho B.C.; Kim S.-W.; Lee K.H.; Wang C.-C.; Seto T.; Huang D.C.-L.; Jung H.H.; Hsu M.-C.; Bogenrieder T.; Chia-Chi Lin |
| 臺大學術典藏 |
2022-09-14T01:30:14Z |
Hepatic tumor in fatty liver: Diagnostic difficulty in ultrasonography
|
Wang C.-C.; Huang G.-T.; Yang P.-M.; CHIEN-HUNG CHEN; Sheu J.-C.; Chen D.-S. |
| 臺大學術典藏 |
2022-09-14T01:29:27Z |
Management consensus guideline for hepatocellular carcinoma: 2020 update on surveillance, diagnosis, and systemic treatment by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan
|
Shao Y.-Y.; Wang S.-Y.; Lin S.-M.; Chen K.-Y.; Tseng J.-H.; Ho M.-C.; Lee R.-C.; Liang P.-C.; Liao L.-Y.; Huang K.-W.; Hu J.-T.; Liang J.-D.; Kee K.-M.; Lin C.-L.; Wang C.-K.; Lu S.-N.; Wang J.-H.; Lee W.-C.; CHIEN-HUNG CHEN; Liu C.-J.; Huang Y.-H.; Wang C.-C.; Wang T.-E.; Chuang P.-H.; Dai C.-Y.; Hsu C.; Chen S.-C.; Hsieh C.-H.; Diagnosis Group, Systemic Therapy Group |
| 臺大學術典藏 |
2022-09-13T08:19:08Z |
TSOC-HFrEF registry: A registry of hospitalized patients with decompensated systolic heart failure: Description of population and management
|
Wang C.-C.; Chang H.-Y.; Yin W.-H.; Wu Y.-W.; Chu P.-H.; CHIH-CHENG WU; Hsu C.-H.; Wen M.-S.; Voon W.-C.; Lin W.-S.; Huang J.-L.; Chen S.-M.; Yang N.-I.; Chang H.-C.; Chang K.-C.; Sung S.-H.; Shyu K.-G.; Lin J.-L.; Mar G.-Y.; Chan K.-C.; Kuo J.-Y.; Wang J.-H.; Chen Z.-C.; Tseng W.-K.; Cherng W.-J. |
| 臺大學術典藏 |
2022-09-13T08:19:07Z |
The Obesity-Mortality Paradox in Patients With Heart Failure in Taiwan and a Collaborative Meta-Analysis for East Asian Patients
|
Lin G.-M.; Li Y.-H.; Yin W.-H.; Wu Y.-W.; Chu P.-H.; CHIH-CHENG WU; Hsu C.-H.; Wen M.-S.; Voon W.-C.; Wang C.-C.; Yeh S.-J.; Lin W.-S.; Chan K.-C.; Chang H.-C.; Chang K.-C.; Chen Z.-C.; Chen S.-M.; Chu P.-H.; Hsu C.-H.; Huang J.-L.; Kuo J.Y.; Lin J.-L.; Lin W.-S.; Mar G.-Y.; Shyu K.-G.; Sung S.-H.; Tseng W.-K.; Voon W.-C.; Wang J.-H.; Wen M.-S.; Yang N.-I. |
| 臺大學術典藏 |
2022-09-13T08:19:05Z |
One-year outcomes of acute decompensated systolic heart failure in Taiwan: Lessons from TSOC-HFreF registry
|
Chang H.-Y.; Wang C.-C.; Wu Y.-W.; Chu P.-H.; CHIH-CHENG WU; Hsu C.-H.; Wen M.-S.; Voon W.-C.; Lin W.-S.; Huang J.-L.; Chen S.-M.; Yang N.-I.; Chang H.-C.; Chang K.-C.; Sung S.-H.; Shyu K.-G.; Lin J.-L.; Mar G.-Y.; Chan K.-C.; Kuo J.-Y.; Wang J.-H.; Chen Z.-C.; Tseng W.-K.; Cherng W.-J.; Yin W.-H. |
| 臺大學術典藏 |
2022-09-09T04:21:36Z |
Long-term risk of end-stage renal diseases with maintenance dialysis among chronic hepatitis C patients after antiviral therapy in Taiwan
|
Hsieh M.-H.; Bair M.-J.; Tsai P.-C.; Tseng K.-C.; Lo C.-C.; Chen C.-Y.; Kuo H.-T.; Hung C.-H.; Lai H.-C.; Peng C.-Y.; Wang J.-H.; Chen J.-J.; Lee P.-L.; Chien R.-N.; Yang C.-C.; Lo G.-H.; JIA-HORNG KAO; Liu C.-J.; Liu C.-H.; Yan S.-L.; Lin C.-Y.; Su W.-W.; Chu C.-H.; Chen C.-J.; Tung S.-Y.; Tai C.-M.; Lin C.-W.; Cheng P.-N.; Chiu Y.-C.; Wang C.-C.; Cheng J.-S.; Tsai W.-L.; Lin H.-C.; Huang Y.-H.; Yeh M.-L.; Huang C.-F.; Huang J.-F.; Dai C.-Y.; Yu M.-L.; Chuang W.-L.; T-COACH investigators |
| 臺大學術典藏 |
2022-09-09T04:21:35Z |
Hepatitis C virus eradication decreases the risks of liver cirrhosis and cirrhosis-related complications (Taiwanese chronic hepatitis C cohort)
|
Hsu W.-F.; Tsai P.-C.; Chen C.-Y.; Tseng K.-C.; Lai H.-C.; Kuo H.-T.; Hung C.-H.; Tung S.-Y.; Wang J.-H.; Chen J.-J.; Lee P.-L.; Chien R.-N.; Lin C.-Y.; Yang C.-C.; Lo G.-H.; Tai C.-M.; Lin C.-W.; JIA-HORNG KAO; Liu C.-J.; Liu C.-H.; Yan S.-L.; Bair M.-J.; Su W.-W.; Chu C.-H.; Chen C.-J.; Lo C.-C.; Cheng P.-N.; Chiu Y.-C.; Wang C.-C.; Cheng J.-S.; Tsai W.-L.; Lin H.-C.; Huang Y.-H.; Huang J.-F.; Dai C.-Y.; Chuang W.-L.; Yu M.-L.; Peng C.-Y. |
| 臺大學術典藏 |
2022-09-09T04:21:31Z |
Nationwide registry of glecaprevir plus pibrentasvir in the treatment of HCV in Taiwan
|
Huang C.-F.; Kuo H.-T.; Chang T.-S.; Lo C.-C.; Hung C.-H.; Huang C.-W.; Chong L.-W.; Cheng P.-N.; Yeh M.-L.; Peng C.-Y.; Cheng C.-Y.; Huang J.-F.; Bair M.-J.; Lin C.-L.; Yang C.-C.; Wang S.-J.; Hsieh T.-Y.; Lee T.-H.; Lee P.-L.; Wu W.-C.; Su W.-W.; Yang S.-S.; Wang C.-C.; Hu J.-T.; Mo L.-R.; Chen C.-T.; Huang Y.-H.; Chang C.-C.; Huang C.-S.; Chen G.-Y.; Kao C.-N.; Tai C.-M.; Liu C.-J.; Lee M.-H.; Tsai P.-C.; Dai C.-Y.; JIA-HORNG KAO; Lin H.-C.; Chuang W.-L.; Chen C.-Y.; Tseng K.-C.; Yu M.-L. |
| 臺大學術典藏 |
2022-09-09T04:21:29Z |
The impact of body mass index on clinicopathological features of nonalcoholic fatty liver disease in Taiwan
|
Lin C.-L.; Tai C.-M.; Huang J.-F.; Liu C.-J.; Chen H.-F.; Cheng P.-N.; Chen C.-Y.; Peng C.-Y.; Wang C.-C.; Weng S.-H.; Tseng T.-C.; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-09-09T04:21:29Z |
Metastatic tumor antigen 1 contributes to hepatocarcinogenesis posttranscriptionally through RNA-binding function
|
Li Y.-T.; Liu C.-J.; JIA-HORNG KAO; Lin L.-F.; Tu H.-C.; Wang C.-C.; Huang P.-H.; Cheng H.-R.; Chen P.-J.; Chen D.-S.; Wu H.-L. |
| 臺大學術典藏 |
2022-09-09T04:21:27Z |
Sofosbuvir/Velpatasvir for Hepatitis?C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan
|
Cheng P.-N.; Mo L.-R.; Chen C.-T.; Chen C.-Y.; Huang C.-F.; Kuo H.-T.; Lo C.-C.; Tseng K.-C.; Huang Y.-H.; Tai C.-M.; Peng C.-Y.; Bair M.-J.; Chen C.-H.; Yeh M.-L.; Lin C.-L.; Lin C.-Y.; Lee P.-L.; Chong L.-W.; Hung C.-H.; Chang T.S.; Huang J.-F.; Yang C.-C.; Hu J.-T.; Lin C.-W.; Wang C.-C.; Su W.-W.; Hsieh T.-Y.; Tsai W.-L.; Lee T.-H.; Chen G.-Y.; Wang S.-J.; Chang C.-C.; Yang S.-S.; Wu W.-C.; Huang C.-S.; Chou K.-H.; Kao C.-N.; Tsai P.-C.; Liu C.-H.; Lee M.-H.; Cheng C.-Y.; Tsai M.-C.; Liu C.-J.; Dai C.-Y.; Lin H.-C.; JIA-HORNG KAO; Chuang W.-L.; Yu M.-L.; TACR investigators |
| 臺大學術典藏 |
2022-09-09T04:21:25Z |
Factors Associated with Significant Platelet Count Improvement in Thrombocytopenic Chronic Hepatitis C Patients Receiving Direct-Acting Antivirals
|
Chen Y.-C.; Chang T.-S.; Chen C.-H.; Cheng P.-N.; Lo C.-C.; Mo L.-R.; Chen C.-T.; Huang C.-F.; Kuo H.-T.; Huang Y.-H.; Tai C.-M.; Peng C.-Y.; Bair M.-J.; Yeh M.-L.; Lin C.-L.; Lin C.-Y.; Lee P.-L.; Chong L.-W.; Hung C.-H.; Huang J.-F.; Yang C.-C.; Hu J.-T.; Lin C.-W.; Wang C.-C.; Su W.-W.; Hsieh T.-Y.; Tsai W.-L.; Lee T.-H.; Chen G.-Y.; Wang S.-J.; Chang C.-C.; Yang S.-S.; Wu W.-C.; Huang C.-S.; Hsiung C.-K.; Kao C.-N.; Tsai P.-C.; Liu C.-H.; Lee M.-H.; Dai C.-Y.; JIA-HORNG KAO; Chuang W.-L.; Lin H.-C.; Chen C.-Y.; Tseng K.-C.; Yu M.-L.; on behalf of TACR investigators |
| 臺大學術典藏 |
2022-09-09T04:21:21Z |
Impact of Sofosbuvir-Based Direct-Acting Antivirals on Renal Function in Chronic Hepatitis C Patients With Impaired Renal Function: A Large Cohort Study From the Nationwide HCV Registry Program (TACR)
|
Huang C.-F.; Tseng K.-C.; Cheng P.-N.; Hung C.-H.; Lo C.-C.; Peng C.-Y.; Bair M.-J.; Yeh M.-L.; Chen C.-H.; Lee P.-L.; Lin C.-Y.; Kuo H.-T.; Chen C.-T.; Yang C.-C.; Huang J.-F.; Tai C.-M.; Hu J.-T.; Lin C.-L.; Su W.-W.; Tsai W.-L.; Huang Y.-H.; Cheng C.-Y.; Lin C.-L.; Wang C.-C.; Yang S.-S.; Mo L.-R.; Chen G.-Y.; Chang C.-C.; Wang S.-J.; Huang C.-S.; Hsieh T.-Y.; Lin C.-W.; Lee T.-H.; Chong L.-W.; Huang C.-W.; Chang S.-N.; Tsai M.-C.; Hsu S.-J.; JIA-HORNG KAO; Liu C.-J.; Liu C.-H.; Lin H.-C.; Lee M.-H.; Tsai P.-C.; Dai C.-Y.; Chuang W.-L.; Chen C.-Y.; Yu M.-L. |
| 臺大學術典藏 |
2022-09-09T04:21:18Z |
Ledipasvir/sofosbuvir for HCV genotype 1, 2, 4–6 infection: Real-world evidence from a nationwide registry in Taiwan
|
Lo C.-C.; Huang C.-F.; Cheng P.-N.; Tseng K.-C.; Chen C.-Y.; Kuo H.-T.; Huang Y.-H.; Tai C.-M.; Peng C.-Y.; Bair M.-J.; Chen C.-H.; Yeh M.-L.; Lin C.-L.; Lin C.-Y.; Lee P.-L.; Chong L.-W.; Hung C.-H.; Chang T.S.; Huang J.-F.; Yang C.-C.; Hu J.-T.; Lin C.-W.; Chen C.-T.; Wang C.-C.; Su W.-W.; Hsieh T.-Y.; Lin C.-L.; Tsai W.-L.; Lee T.-H.; Chen G.-Y.; Wang S.-J.; Chang C.-C.; Mo L.-R.; Yang S.-S.; Wu W.-C.; Huang C.-S.; Hsiung C.-K.; Kao C.-N.; Tsai P.-C.; Liu C.-H.; Lee M.-H.; Liu C.-J.; Dai C.-Y.; Chuang W.-L.; Lin H.-C.; JIA-HORNG KAO; Yu M.-L.; TACR investigators |
| 臺大學術典藏 |
2022-09-07T07:41:40Z |
The benefit of pretreatment esophageal screening with image-enhanced endoscopy on the survival of patients with hypopharyngeal cancer
|
Wang W.-L.; Wang C.-P.; Wang H.-P.; Lee C.-T.; Chang C.-Y.; Tai C.-M.; Tseng C.-H.; Hwang T.-Z.; Wang C.-C.; Lo J.-L.; Tseng P.-H.; HAN-MO CHIU; Lee J.-M.; Ko J.-Y.; Lou P.-J.; Wu M.-S.; Lee Y.-C.; Lin J.-T. |
| 臺大學術典藏 |
2022-09-07T06:50:31Z |
Narrow-band imaging with magnifying endoscopy for the screening of esophageal cancer in patients with primary head and neck cancers
|
Lee C.T.; Chang C.Y.; YI-CHIA LEE; Tai C.M.; Wang W.L.; Tseng P.H.; Hwang J.C.; Hwang T.Z.; Wang C.C.; Lin J.-T. |
| 臺大學術典藏 |
2022-09-07T06:50:30Z |
Risk factors for developing synchronous esophageal neoplasia in patients with head and neck cancer
|
Wang W.-L.; Lee C.-T.; YI-CHIA LEE; Hwang T.-Z.; Wang C.-C.; Hwang J.-C.; Tai C.-M.; Chang C.-Y.; Tsai S.-S.; Wang C.-P.; Ko J.-Y.; Lin J.-T. |
| 臺大學術典藏 |
2022-09-07T06:39:15Z |
Augmented renal clearance is associated with inadequate antibiotic pharmacokinetic/ pharmacodynamic target in Asian ICU population: a prospective observational study
|
Wu C.-C.; Tai C.-H.; Liao W.-Y.; Wang C.-C.; Kuo C.-H.; SHU-WEN LIN; Ku S.-C. |
| 臺大學術典藏 |
2022-09-07T06:39:10Z |
Metabolomics analysis of plasma reveals voriconazole-induced hepatotoxicity is associated with oxidative stress
|
Wu S.-L.; Cheng C.-N.; Wang C.-C.; SHU-WEN LIN; Kuo C.-H. |
| 臺大學術典藏 |
2022-09-07T06:39:08Z |
Impact of high plasma concentrations of linezolid in Taiwanese adult patients— therapeutic drug monitoring in improving adverse drug reactions
|
Cheng C.-N.; Wu C.-C.; Kuo C.-H.; Wang C.-C.; Wang J.-T.; Lin Y.-T.; Jhang R.-S.; SHU-WEN LIN |
| 臺大學術典藏 |
2022-09-07T06:39:05Z |
Influenza vaccination and the risk of COVID-19 infection and severe illness in older adults in the United States
|
Huang K.; SHU-WEN LIN; Sheng W.-H.; Wang C.-C. |
| 臺大學術典藏 |
2022-09-06T08:57:04Z |
Helicobacter pylori infection and age on the development of intestinal metaplasia - A multiple logistic regression analysis
|
Wang C.-C.; MING-SHIANG WU; Wang H.-H.; Wang H.-P.; Lee W.-C.; Shun C.-T.; Lin J.-T. |
| 臺大學術典藏 |
2022-09-06T08:38:43Z |
Impact of integrated medication management program on medication errors in a medical center: an interrupted time series study
|
Chen K.-L.; Hunag C.-F.; Sheng W.-H.; Chen Y.-K.; Wang C.-C.; LI-JIUAN SHEN |
| 臺大學術典藏 |
2022-09-06T07:43:05Z |
The benefit of pretreatment esophageal screening with image-enhanced endoscopy on the survival of patients with hypopharyngeal cancer
|
Wang W.-L.; Wang C.-P.; Wang H.-P.; Lee C.-T.; Chang C.-Y.; Tai C.-M.; Tseng C.-H.; Hwang T.-Z.; Wang C.-C.; Lo J.-L.; Tseng P.-H.; Chiu H.-M.; Lee J.-M.; Ko J.-Y.; Lou P.-J.; MING-SHIANG WU; Lee Y.-C.; Lin J.-T. |
| 臺大學術典藏 |
2022-09-06T02:42:09Z |
2016 Guidelines of the Taiwan Heart Rhythm Society and the Taiwan Society of Cardiology for the management of atrial fibrillation
|
Chiang C.-E.; Wu T.-J.; Ueng K.-C.; Chao T.-F.; Chang K.-C.; Wang C.-C.; Lin Y.-J.; Yin W.-H.; Kuo J.-Y.; Lin W.-S.; Tsai C.-T.; Liu Y.-B.; Lee K.-T.; Lin L.-J.; LIAN-YU LIN; Wang K.-L.; Chen Y.-J.; Chen M.-C.; Cheng C.-C.; Wen M.-S.; Chen W.-J.; Chen J.-H.; Lai W.-T.; Chiou C.-W.; Lin J.-L.; Yeh S.-J.; Chen S.-A. |
| 臺大學術典藏 |
2022-09-06T02:41:53Z |
Gender difference in clinical and genetic characteristics of Brugada syndrome: SADS-TW BrS registry
|
Chen C.-Y.J.; Juang J.-M.J.; LIAN-YU LIN; Liu Y.-B.; Ho L.-T.; Yu C.-C.; Huang H.-C.; Lin T.-T.; Liao M.-C.; Chen J.-J.; Hwang J.-J.; Chen W.-J.; Yeh S.-F.S.; Yang D.-H.; Chiang F.-T.; Lin J.-L.; Lai L.-P.; Horie M.; Wu M.-H.; Wu T.-J.; Chen S.-A.; Wang C.-C.; Chang K.-C.; Feng A.-N.; Lin Y.-J.; Ueng K.-C.; Tsao H.-M.; Huang J.-L.; Tsai W.-C.; Tsai C.-F.; Chang S.-L.; Lo L.-W.; Hu Y.-F.; Chung F.-P.; Chang C.-J.; Lo H.-M.; Chiang M.-C.; Hsia C.-P.; Liu J.-F.; Chiu S.-N.; Lin M.-T.; Chua S.-K.; Hsieh Y.-C.; Li C.-H.; Liao Y.-C.; Lin H.-H.; Liu Z.-Z.; Ye G.-H.; Chiu W.-R.; Chang J.-R.; Feng W.-J.; Chang S.-X.; Lei M.-H.; Ko W.-C.; Kong C.-W.; Kuo C.-T.; Huang B.-X.; Li K.-T.; Chen W.-D.; Luo J.-L.; Lin J.-Y.; Tsai T.-N.; Hsu C.-T.; Lin L.-R.; Chen R.-Y.; Li P.-T.; Stephen Huang S.K.; SADS-TW BrS Registry |
| 臺大學術典藏 |
2022-09-06T01:29:26Z |
The waist-to-body mass index ratio as an anthropometric predictor for cardiovascular outcome in subjects with established atherosclerotic cardiovascular disease
|
Hsuan C.-F.; Lin F.-J.; Lee T.-L.; Yang K.-C.; Tseng W.-K.; Wu Y.-W.; Yin W.-H.; Yeh H.-I.; Chen J.-W.; Wu C.-C.; Chang W.-T.; Lee Y.-H.; Chen J.-W.; Sheu H.-H.; Hsieh I.-C.; Chen Y.-S.; Liu M.-E.; Chen C.-H.; Lin L.-Y.; Yeh H.-I.; Sung S.-H.; Liu P.-Y.; Wu I.-H.; Wang Z.-H.; Chiu K.-M.; Kuo C.-T.; Wang T.-D.; Hung C.-L.; Wang C.-H.; Wang C.-C.; Wang C.-Y.; JIANN-SHING JENG; Lin T.-H.; Kao H.-L.; Chu P.-H.; Lin F.-J.; Chen Z.-C.; Chang K.-C.; Yin W.-H.; Tseng W.-K.; The Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators |
| 臺大學術典藏 |
2022-08-19T00:21:12Z |
Phase I study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of fluorouracil/leucovorin for advanced pancreatic cancer
|
Ch'ang H.-J.; Wang C.-C.; Cheng A.-L.; CHIUN HSU; Lu Y.-S.; Chang M.-C.; Lin J.-T.; Wang H.-P.; Shiah H.-S.; Liu T.-W.; Chang J.-Y.; Whang-Peng J.; Chen L.-T. |
| 臺大學術典藏 |
2022-08-19T00:20:39Z |
Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan
|
Local ablation group, Surveillance group, Diagnosis group, Staging group, Surgery group, TACE/TARE/HAI group, Target therapy/systemic therapy group, Radiotherapy group, Prevention group, Drafting group; Ni Y.-H.; Lin C.-L.; Hsu Y.-C.; Hsu C.-W.; Wu C.-Y.; Wu J.-C.; Cheng J.C.-H.; Leung S.W.; Chen S.-W.; Hsu H.-C.; Hong J.-H.; Wang P.-M.; Wang P.-M.; Ting C.-T.; Lee W.-C.; Chau G.-Y.; Wang C.-C.; Lee K.-T.; Huang Y.-H.; Ho M.-C.; Lin S.-M.; Huang G.-T.; Chen K.-Y.; Lin X.-Z.; Hwang J.-I.; Chiou Y.-Y.; Wang C.-K.; Hu J.-T.; Chen S.-C.; Liang P.-C.; Lee R.-C.; Wu D.-K.; Lin C.-Y.; Lin C.-C.; Cheng A.-L.; CHIUN HSU; Chao Y.; Chen L.-T.; Lee P.-H.; Liao L.-Y.; Huo T.-I.; Wu C.-C.; Hung C.-F.; Huang S.-F.; Yang S.-S.; Chen R.-C.; Chen C.-H.; Dai C.-Y.; Wang T.-E.; Su C.-W.; Wang J.-H.; Lu S.-N. |
| 臺大學術典藏 |
2022-08-12T06:27:58Z |
Diffuse expression of RNA-binding protein IMP3 predicts high-stage lymph node metastasis and poor prognosis in colorectal adenocarcinoma
|
Yuan R.-H.; Wang C.-C.; Chou C.-C.; KING-JEN CHANG; Lee P.-H.; Jeng Y.-M. |
| 臺大學術典藏 |
2022-08-12T06:27:47Z |
Prognostic molecular markers in Women aged 35 years or younger with breast cancer: Is there a difference from the older patients?
|
Lin C.-H.; Lu Y.-S.; Huang C.-S.; Kuo K.-T.; Wang C.-C.; You S.-L.; Lin P.-H.; Chang D.-Y.; Kuo W.-H.; KING-JEN CHANG; Cheng A.-L. |
| 臺大學術典藏 |
2022-08-10T02:37:42Z |
Nivolumab safety and efficacy in advanced, platinum-resistant, non-small cell lung cancer, radical radiotherapy-ineligible patients: A phase II study in Taiwan
|
Chen Y.-M.; CHIH-HSIN YANG; Su W.-C.; Chong I.-W.; Hsia T.-C.; Lin M.-C.; Chang G.-C.; Chiu C.-H.; Ho C.-C.; Wu S.-Y.; Hung J.-Y.; Wang C.-C.; Yang T.-Y.; Yu C.-J. |
| 臺大學術典藏 |
2022-08-10T02:37:37Z |
Efficacy of Aumolertinib (HS-10296) in Patients With Advanced EGFR T790M+ NSCLC: Updated Post-National Medical Products Administration Approval Results From the APOLLO Registrational Trial
|
Lu S.; Wang Q.; Zhang G.; Dong X.; Yang C.-T.; Song Y.; Chang G.-C.; Lu Y.; Pan H.; Chiu C.-H.; Wang Z.; Feng J.; Zhou J.; Xu X.; Guo R.; Chen J.; Yang H.; Chen Y.; Yu Z.; Shiah H.-S.; Wang C.-C.; Yang N.; Fang J.; Wang P.; Wang K.; Hu Y.; He J.; Shi J.; Chen S.; Wu Q.; Sun C.; Li C.; Wei H.; Cheng Y.; Su W.-C.; Hsia T.-C.; Cui J.; Sun Y.; Ou S.-H.I.; Zhu V.W.; CHIH-HSIN YANG |
| 臺大學術典藏 |
2022-07-25T06:31:24Z |
The waist-to-body mass index ratio as an anthropometric predictor for cardiovascular outcome in subjects with established atherosclerotic cardiovascular disease
|
Hsuan C.-F.; Lin F.-J.; Lee T.-L.; KAI-CHIEN YANG; Tseng W.-K.; Wu Y.-W.; Yin W.-H.; Yeh H.-I.; Chen J.-W.; Wu C.-C.; Chang W.-T.; Lee Y.-H.; Sheu H.-H.; Hsieh I.-C.; Chen Y.-S.; Liu M.-E.; Chen C.-H.; Lin L.-Y.; Sung S.-H.; Liu P.-Y.; Wu I.-H.; Wang Z.-H.; Chiu K.-M.; Kuo C.-T.; Wang T.-D.; Hung C.-L.; Wang C.-H.; Wang C.-C.; Wang C.-Y.; Jeng J.-S.; Lin T.-H.; Kao H.-L.; Chu P.-H.; Chen Z.-C.; Chang K.-C.; The Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators |
| 臺大學術典藏 |
2022-07-14T07:25:27Z |
Simvastatin and ROCK Inhibitor Y-27632 Inhibit Myofibroblast Differentiation of Graves’ Ophthalmopathy-Derived Orbital Fibroblasts via RhoA-Mediated ERK and p38 Signaling Pathways
|
Wei Y.-H.; Liao S.-L.; Wang S.-H.; Wang C.-C.; CHANG-HAO YANG |
| 臺大學術典藏 |
2022-07-14T07:25:27Z |
Simvastatin Inhibits CYR61 Expression in Orbital Fibroblasts in Graves' Ophthalmopathy through the Regulation of FoxO3a Signaling
|
Wei Y.-H.; Liao S.-L.; Wang C.-C.; Wang S.-H.; Tang W.-C.; CHANG-HAO YANG |
| 臺大學術典藏 |
2022-07-11T09:51:09Z |
Simvastatin Inhibits CYR61 Expression in Orbital Fibroblasts in Graves' Ophthalmopathy through the Regulation of FoxO3a Signaling
|
Wei Y.-H.; Liao S.-L.; Wang C.-C.; Wang S.-H.; Tang W.-C.; CHANG-HAO YANG |
| 臺大學術典藏 |
2022-07-11T09:51:08Z |
Simvastatin and ROCK Inhibitor Y-27632 Inhibit Myofibroblast Differentiation of Graves’ Ophthalmopathy-Derived Orbital Fibroblasts via RhoA-Mediated ERK and p38 Signaling Pathways
|
Wei Y.-H.; Liao S.-L.; Wang S.-H.; Wang C.-C.; CHANG-HAO YANG |
| 臺大學術典藏 |
2022-06-30T02:05:19Z |
Investigating the structure of the Milun Fault from surface ruptures of the 2018 Hualien Earthquake
|
Hsu Y.-C.; Chang C.-P.; Yen J.-Y.; Kuo-Chen H.; Wang C.-C.; Hsu Y.-C.; Chang C.-P.; Yen J.-Y.; Kuo-Chen H.; Wang C.-C.; HAO KUO-CHEN |
